查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
骨关节炎的全球市场 - 市场占有率·规模·趋势·产业分析:各治疗类型，各疾病类型，各流通管道，各给药途径，各地区，市场区隔预测(2022年～2030年)
市场调查报告书
商品编码
1150067

骨关节炎的全球市场 - 市场占有率·规模·趋势·产业分析:各治疗类型，各疾病类型，各流通管道，各给药途径，各地区，市场区隔预测(2022年～2030年)

Osteoarthritis Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drugs, Assistive Devices); By Disease Type; By Distribution Channel; By Route of Administration; By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

全球骨关节炎的市场规模在2030年前将达到153亿美元。

本报告提供全球骨关节炎市场调查，提供市场概要，市场规模和预测，趋势，促进因素·阻碍因素，各治疗类型·各疾病类型·各流通管道·各给药途径·各地区等分析，再加上企业简介等资讯。

目录

第1章 简介

  • 报告的说明
    • 调查的目的
    • 市场范围
    • 前提条件
  • 利害关係者

第2章 摘要整理

  • 市场概况

第3章 调查手法

  • 概要
    • 资料探勘
  • 资讯来源
    • 一次资讯
    • 二次资讯

第4章 全球骨关节炎市场洞察

  • 骨关节炎 - 产业的概述
  • 骨关节炎市场动态
    • 促进因素和机会
    • 阻碍因素与课题
  • 波特的五力分析
    • 供给企业谈判力
    • 新加入厂商者的威胁
    • 买方议价能力
    • 替代品的威胁
    • 现有企业间的竞争力
  • 大环境分析
  • 骨关节炎产业趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球骨关节炎市场:各治疗类型

  • 主要调查结果
  • 简介
    • 全球骨关节炎市场，各治疗类型(2018年～2030年)
  • 药物
    • 全球骨关节炎市场，药物，各地区(2018年～2030年)
    • 关节内补充药
    • 非类固醇消炎剂
    • 止痛药
    • 皮质类固醇
  • 辅助设备
    • 全球骨关节炎市场，辅助设备，各地区(2018年～2030年)

第6章 全球骨关节炎市场:各流通管道

  • 主要调查结果
  • 简介
    • 全球骨关节炎市场，各流通管道(2018年～2030年)
  • 医院药局
    • 全球骨关节炎市场，医院药局，各地区(2018年～2030年)
  • 零售药局
    • 全球骨关节炎市场，零售药局，各地区(2018年～2030年)
  • 药妆店
    • 全球骨关节炎市场，药妆店，各地区(2018年～2030年)
  • 电子商务
    • 全球骨关节炎市场，电子商务，各地区(2018年～2030年)

第7章 全球骨关节炎市场:各疾病类型

  • 主要调查结果
  • 简介
    • 全球骨关节炎市场，各疾病类型(2018年～2030年)
  • 膝的骨关节炎
    • 全球骨关节炎市场，膝的骨关节炎，各地区(2018年～2030年)
  • 脊椎的骨关节炎
    • 全球骨关节炎市场，脊椎的骨关节炎，各地区(2018年～2030年)
  • 脚·脚踝的骨关节炎
    • 全球骨关节炎市场，脚·脚踝的骨关节炎，各地区(2018年～2030年)
  • 肩膀的骨关节炎
    • 全球骨关节炎市场，肩膀的骨关节炎，各地区(2018年～2030年)
  • 手的骨关节炎
    • 全球骨关节炎市场，手的骨关节炎，各地区(2018年～2030年)

第8章 全球骨关节炎市场:各给药途径

  • 主要调查结果
  • 简介
    • 全球骨关节炎市场，各给药途径(2018年～2030年)
  • 非口服途径
    • 全球骨关节炎市场，各非口服途径，各地区(2018年～2030年)
  • 局部途径
    • 全球骨关节炎市场，各局部途径，各地区(2018年～2030年)
  • 口服途径
    • 全球骨关节炎市场，各口服途径，各地区(2018年～2030年)

第9章 全球骨关节炎市场:各地区

  • 主要调查结果
  • 简介
    • 骨关节炎市场评估，各地区(2018年～2030年)
  • 骨关节炎市场 - 北美
    • 北美:骨关节炎市场，各治疗类型(2018年～2030年)
    • 北美:骨关节炎市场，各给药途径(2018年～2030年)
    • 北美:骨关节炎市场，各流通管道(2018年～2030年)
    • 北美:骨关节炎市场，各疾病类型(2018年～2030年)
    • 骨关节炎市场 - 美国
    • 骨关节炎市场 - 加拿大
  • 骨关节炎市场 - 欧洲
    • 欧洲:骨关节炎市场，各治疗类型(2018年～2030年)
    • 欧洲:骨关节炎市场，各给药途径(2018年～2030年)
    • 欧洲:骨关节炎市场，各流通管道(2018年～2030年)
    • 欧洲:骨关节炎市场，各疾病类型(2018年～2030年)
    • 骨关节炎市场 - 英国
    • 骨关节炎市场 - 法国
    • 骨关节炎市场 - 德国
    • 骨关节炎市场 - 义大利
    • 骨关节炎市场 - 西班牙
    • 骨关节炎市场 - 荷兰
    • 骨关节炎市场 - 俄罗斯
  • 骨关节炎市场 - 亚太地区
    • 亚太地区:骨关节炎市场，各治疗类型(2018年～2030年)
    • 亚太地区:骨关节炎市场，各给药途径(2018年～2030年)
    • 亚太地区:骨关节炎市场，各流通管道(2018年～2030年)
    • 亚太地区:骨关节炎市场，各疾病类型(2018年～2030年)
    • 骨关节炎市场 - 中国
    • 骨关节炎市场 - 印度
    • 骨关节炎市场 - 日本
    • 骨关节炎市场 - 马来西亚
    • 骨关节炎市场 - 印尼
    • 骨关节炎市场 - 韩国
  • 骨关节炎市场 - 中东·非洲
    • 中东·非洲:骨关节炎市场，各治疗类型(2018年～2030年)
    • 中东·非洲:骨关节炎市场，各给药途径(2018年～2030年)
    • 中东·非洲:骨关节炎市场，各流通管道(2018年～2030年)
    • 中东·非洲:骨关节炎市场，各疾病类型(2018年～2030年)
    • 骨关节炎市场 - 沙乌地阿拉伯
    • 骨关节炎市场 - 南非
    • 骨关节炎市场 - 以色列
    • 骨关节炎市场 - 阿拉伯联合大公国
  • 骨关节炎市场 - 南美
    • 南美:骨关节炎市场，各治疗类型(2018年～2030年)
    • 南美:骨关节炎市场，各给药途径(2018年～2030年)
    • 南美:骨关节炎市场，各流通管道(2018年～2030年)
    • 南美:骨关节炎市场，各疾病类型(2018年～2030年)
    • 骨关节炎市场 - 墨西哥
    • 骨关节炎市场 - 巴西
    • 骨关节炎市场 - 阿根廷

第10章 竞争情形

  • 扩大·收购的分析
    • 扩大
    • 收购
  • 伙伴关係/合作/协定/公开

第11章 企业简介

  • ABIOGEN PHARMA S.p.A
  • Assertio Therapeutics, Inc
  • Abbott Laboratories Incorporation
  • Apotex Inc
  • Ampio Pharmaceuticals Inc
  • Bayer AG
  • Eli Lilly and Company
  • Horizon Therapeutics plc
  • Johnson & Johnson
  • Merck Sharp & Dohme Corp
  • Mylan N.V
  • Novartis AG
  • Pfizer Inc
  • Reckitt Benckiser Group PLC
  • Sanofi SA
  • Tolmar Pharmaceuticals, Inc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet Holding
Product Code: PM1348

The global osteoarthritis market size is expected to reach USD 15.30 billion by 2030, according to a new study by Polaris Market Research. The report "Osteoarthritis Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drugs, Assistive Devices); By Disease Type; By Distribution Channel; By Route of Administration; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising senior population and the rising prevalence of osteoarthritis are the main drivers of the market. For instance, as per the Centers for Disease Control and Prevention (CDC), 54.4 million US people, or one in four, have some type of arthritis, and by 2040, that number is expected to rise to 78 million.

Although there are more than 100 different kinds of arthritis, osteoarthritis (OA), which affects 32.5 million US adults, is the most widespread variety. 88% of those with OA are 45 years of age or older, and 43% are 65 years of age or older. There are significant societal and individual costs associated with the high frequency of arthritis.

Additionally, there have been technological developments, and improvements in diagnostics, are the factors boosting the market growth over the forecast period. Knee kinesiography, an advanced medical tool, is transforming how doctors treat osteoarthritis of the knee. As stated by the Public Health Agency of Canada, this type of osteoarthritis affects about four million Canadians or 13.6% of the community. When compared to males (11.1% and 7.5 per 1,000 persons per year), women(16.1% and 10.0 per 1,000 persons per year, respectively) have a greater frequency and prevalence of osteoarthritis diagnoses.

Further, in January 2022, TrialSpark announced the establishment of High Line Bio after acquiring from Merck KGaA the global license to sprifermin. Sprifermin is a technologically advanced disease-modifying recombinant version of human fibroblast development factor 18 that is being investigated as potential osteoarthritis (OA) treatment by encouraging cartilage formation.

One of the most unmet medical requirements among musculoskeletal disorders, OA is a degenerative joint disease that occurs partially due to cartilage loss. Thus, the rising prevalence of OA among the senior population and the development of technologically advanced treatments for OA are the factors boosting the market growth over the forecast period.

Additionally, the desire for minimally invasive surgical methods, greater public awareness, better treatment alternatives, and patient willingness to pursue therapy are all anticipated to support the expansion of the market.

Osteoarthritis Market Report Highlights

Knee osteoarthritis segment is anticipated to grow at a significant CAGR over the forecast period due to the high occurrence of knee osteoarthritis across the globe

Parental route segment accounted for the highest revenue share. This can be ascribed to the widespread use of the parenteral route for giving osteoarthritis treatments because of its simplicity, improved pharmacokinetics, and improved pharmacodynamics, which lead to higher patient compliance.

Asia Pacific is expected to grow at a fastest CAGR over the projected period on account of a rise in osteoarthritis incidence, a growth in the number of women, an expansion in health care spending, and a lack of physical activity

The global market includes Apotex Inc., Ampio Pharmaceuticals Inc., Bayer AG, Flexion Therapeutics, Inc., GlaxoSmithKline PLC, Horizon Therapeutics plc, Reckitt Benckiser Group PLC, Sanofi SA, Tolmar Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., and Zimmer Biomet Holding

Polaris Market Research has segmented the osteoarthritis market report based on treatment type, disease type, distribution channel, route of administration, and region:

Osteoarthritis, Treatment Type Outlook (Revenue - USD Billion, 2018 - 2030)

Drugs

Viscosupplementation Agents

Nonsteroidal Anti-inflammatory Drugs

Naproxen

Aspirin

Diclofenac

Ibuprofen

Other NSAIDs

Analgesics

Duloxetine

Acetaminophen

Corticosteroids

Assistive Devices

Osteoarthritis, Disease Type Outlook (Revenue - USD Billion, 2018 - 2030)

Knee Osteoarthritis

Spine Osteoarthritis

Foot & Ankle Osteoarthritis

Shoulder Osteoarthritis

Hand Osteoarthritis

Osteoarthritis, Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)

Hospital Pharmacies

Retail Pharmacies

Drug Stores

E-Commerce

Osteoarthritis, Route of Administration Outlook (Revenue - USD Billion, 2018 - 2030)

Parenteral Route

Topical Route

Oral Route

Osteoarthritis, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Osteoarthritis Market Insights

  • 4.1. Osteoarthritis - Industry Snapshot
  • 4.2. Osteoarthritis Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of osteoarthritis
      • 4.2.1.2. Growing population susceptible to osteoarthritis
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Commercialization of alternatives
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Osteoarthritis Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Osteoarthritis Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • 5.3. Drugs
    • 5.3.1. Global Osteoarthritis Market, by Drugs, by Region, 2018 - 2030 (USD Billion)
    • 5.3.2. Viscosupplementation Agents
      • 5.3.2.1. Global Osteoarthritis Market, by Viscosupplementation Agents, by Region, 2018 - 2030 (USD Billion)
    • 5.3.3. Nonsteroidal Anti-inflammatory Drugs
      • 5.3.3.1. Global Osteoarthritis Market, by Nonsteroidal Anti-inflammatory Drugs, by Region, 2018 - 2030 (USD Billion)
      • 5.3.3.2. Naproxen
      • 5.3.3.2.1. Global Osteoarthritis Market, by Naproxen, by Region, 2018 - 2030 (USD Billion)
      • 5.3.3.3. Aspirin
      • 5.3.3.3.1. Global Osteoarthritis Market, by Aspirin, by Region, 2018 - 2030 (USD Billion)
      • 5.3.3.4. Diclofenac
      • 5.3.3.4.1. Global Osteoarthritis Market, by Diclofenac, by Region, 2018 - 2030 (USD Billion)
      • 5.3.3.5. Ibuprofen
      • 5.3.3.5.1. Global Osteoarthritis Market, by Ibuprofen, by Region, 2018 - 2030 (USD Billion)
      • 5.3.3.6. Other NSAIDs
      • 5.3.3.6.1. Global Osteoarthritis Market, by Other NSAIDs, by Region, 2018 - 2030 (USD Billion)
    • 5.3.4. Analgesics
      • 5.3.4.1. Global Osteoarthritis Market, by Analgesics, by Region, 2018 - 2030 (USD Billion)
      • 5.3.4.2. Duloxetine
      • 5.3.4.2.1. Global Osteoarthritis Market, by Duloxetine, by Region, 2018 - 2030 (USD Billion)
      • 5.3.4.3. Acetaminophen
      • 5.3.4.3.1. Global Osteoarthritis Market, by Acetaminophen, by Region, 2018 - 2030 (USD Billion)
    • 5.3.5. Corticosteroids
      • 5.3.5.1. Global Osteoarthritis Market, by Corticosteroids, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Assistive Devices
    • 5.4.1. Global Osteoarthritis Market, by Assistive Devices, by Region, 2018 - 2030 (USD Billion)

6. Global Osteoarthritis Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Osteoarthritis Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Retail Pharmacies
    • 6.4.1. Global Osteoarthritis Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Drug Stores
    • 6.5.1. Global Osteoarthritis Market, by Drug Stores, by Region, 2018 - 2030 (USD Billion)
  • 6.6. E-Commerce
    • 6.6.1. Global Osteoarthritis Market, by E-Commerce, by Region, 2018 - 2030 (USD Billion)

7. Global Osteoarthritis Market, by Disease Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • 7.3. Knee Osteoarthritis
    • 7.3.1. Global Osteoarthritis Market, by Knee Osteoarthritis, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Spine Osteoarthritis
    • 7.4.1. Global Osteoarthritis Market, by Spine Osteoarthritis, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Foot & Ankle Osteoarthritis
    • 7.5.1. Global Osteoarthritis Market, by Foot & Ankle Osteoarthritis, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Shoulder Osteoarthritis
    • 7.6.1. Global Osteoarthritis Market, by Shoulder Osteoarthritis, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Hand Osteoarthritis
    • 7.7.1. Global Osteoarthritis Market, by Hand Osteoarthritis, by Region, 2018 - 2030 (USD Billion)

8. Global Osteoarthritis Market, by Route of Administration

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • 8.3. Parenteral Route
    • 8.3.1. Global Osteoarthritis Market, by Parenteral Route, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Topical Route
    • 8.4.1. Global Osteoarthritis Market, by Topical Route, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Oral Route
    • 8.5.1. Global Osteoarthritis Market, by Oral Route, by Region, 2018 - 2030 (USD Billion)

9. Global Osteoarthritis Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Osteoarthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Osteoarthritis Market - North America
    • 9.3.1. North America: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.3.5. Osteoarthritis Market - U.S.
      • 9.3.5.1. U.S.: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.3.6. Osteoarthritis Market - Canada
      • 9.3.6.1. Canada: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • 9.4. Osteoarthritis Market - Europe
    • 9.4.1. Europe: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.4.5. Osteoarthritis Market - UK
      • 9.4.5.1. UK: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.4.6. Osteoarthritis Market - France
      • 9.4.6.1. France: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.4.7. Osteoarthritis Market - Germany
      • 9.4.7.1. Germany: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.4.8. Osteoarthritis Market - Italy
      • 9.4.8.1. Italy: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.4.9. Osteoarthritis Market - Spain
      • 9.4.9.1. Spain: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.4.10. Osteoarthritis Market - Netherlands
      • 9.4.10.1. Netherlands: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.4.11. Osteoarthritis Market - Russia
      • 9.4.11.1. Russia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Russia.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Russia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Russia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • 9.5. Osteoarthritis Market - Asia Pacific
    • 9.5.1. Asia Pacific: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.5.5. Osteoarthritis Market - China
      • 9.5.5.1. China: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.5.6. Osteoarthritis Market - India
      • 9.5.6.1. India: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.5.7. Osteoarthritis Market - Japan
      • 9.5.7.1. Japan: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.5.8. Osteoarthritis Market - Malaysia
      • 9.5.8.1. Malaysia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.5.9. Osteoarthritis Market - Indonesia
      • 9.5.9.1. Indonesia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.5.10. Osteoarthritis Market - South Korea
      • 9.5.10.1. South Korea: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • 9.6. Osteoarthritis Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.6.5. Osteoarthritis Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.6.6. Osteoarthritis Market - South Africa
      • 9.6.6.1. South Africa: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.6.7. Osteoarthritis Market - Israel
      • 9.6.7.1. Israel: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.6.8. Osteoarthritis Market - UAE
      • 9.6.8.1. UAE: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • 9.7. Osteoarthritis Market - Latin America
    • 9.7.1. Latin America: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.7.5. Osteoarthritis Market - Mexico
      • 9.7.5.1. Mexico: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.7.6. Osteoarthritis Market - Brazil
      • 9.7.6.1. Brazil: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.7.7. Osteoarthritis Market - Argentina
      • 9.7.7.1. Argentina: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. ABIOGEN PHARMA S.p.A
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Assertio Therapeutics, Inc
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Abbott Laboratories Incorporation
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Apotex Inc
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Ampio Pharmaceuticals Inc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Bayer AG
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Eli Lilly and Company
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Horizon Therapeutics plc
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Johnson & Johnson
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Merck Sharp & Dohme Corp
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Mylan N.V
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Novartis AG
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Pfizer Inc
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Reckitt Benckiser Group PLC
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Sanofi SA
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Tolmar Pharmaceuticals, Inc
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Teva Pharmaceutical Industries Ltd
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. Zimmer Biomet Holding
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development

List of Tables

  • Table 1 Global Osteoarthritis Market, by Treatment Type, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Osteoarthritis Market, by Distribution Channel, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Osteoarthritis Market, by Disease Type, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Osteoarthritis Market, by Route of Administration, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Osteoarthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 6 North America: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 7 North America: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 8 North America: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 9 North America: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 11 U.S.: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 14 Canada: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 15 Canada: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 16 Canada: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 18 Europe: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 19 Europe: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 20 Europe: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 21 Europe: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 22 Germany: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 26 France: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 27 France: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 France: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 29 France: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 30 UK: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 31 UK: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 32 UK: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 33 UK: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 34 Italy: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 35 Italy: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 36 Italy: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 37 Italy: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 38 Netherlands: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 39 Netherlands: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Netherlands: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 41 Netherlands: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 42 Spain: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 43 Spain: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 44 Spain: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 45 Spain: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 46 Russia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 47 Russia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 48 Russia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 49 Russia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 54 China: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 55 China: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 56 China: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 57 China: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 58 Japan: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 59 Japan: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 60 Japan: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 61 Japan: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 62 India: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 63 India: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 64 India: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 65 India: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 66 Indonesia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 67 Indonesia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 68 Indonesia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 69 Indonesia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 70 Malaysia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 71 Malaysia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 72 Malaysia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 73 Malaysia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 74 South Korea: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 75 South Korea: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 76 South Korea: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 77 South Korea: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 78 Latin America: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 79 Latin America: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 80 Latin America: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 81 Latin America: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 83 Brazil: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 84 Brazil: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 85 Brazil: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 86 Mexico: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 87 Mexico: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 88 Mexico: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 89 Mexico: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 90 Argentina: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 91 Argentina: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 92 Argentina: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 93 Argentina: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 94 Middle East & Africa: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 95 Middle East & Africa: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 96 Middle East & Africa: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 98 UAE: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 99 UAE: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 100 UAE: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 101 UAE: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 106 South Africa: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 107 South Africa: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 108 South Africa: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 109 South Africa: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  • Table 110 Israel: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  • Table 111 Israel: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 112 Israel: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 113 Israel: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Osteoarthritis Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Route of Administration

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Treatment Type

Figure 7. Global Osteoarthritis Market, by Treatment Type, 2021 & 2030 (USD Billion)

Figure 8. Market by Route of Administration

Figure 9. Global Osteoarthritis Market, by Route of Administration, 2021 & 2030 (USD Billion)

Figure 10. Market by Distribution Channel

Figure 11. Global Osteoarthritis Market, by Distribution Channel, 2021 & 2030 (USD Billion)

Figure 12. Market by Disease Type

Figure 13. Global Osteoarthritis Market, by Disease Type, 2021 & 2030 (USD Billion)

Figure 14. Osteoarthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Osteoarthritis Market